Institutional-grade biotech intelligence, built for every investor.
At BiopharmaWatch, we are dedicated to empowering investors by providing independent, timely, and accurate insights into the biotech and pharmaceutical industries. Our mission is to democratize access to high-quality investment research, enabling informed decision-making in these dynamic sectors.
Founded in 2023, BiopharmaWatch is a biotech market intelligence platform specializing in FDA catalyst tracking, clinical trial analytics, and pharmaceutical investment research. Our team combines deep biotech domain expertise with software engineering to deliver tools and analysis that were previously only available to institutional investors.
We offer in-depth coverage of over 2,000 biotech and pharmaceutical companies, analyzing critical metrics across the entire drug development lifecycle. Our platform includes:
We believe transparency builds trust. Here is how we source, verify, and maintain the data on BiopharmaWatch:
All FDA regulatory data is sourced from FDA.gov, ClinicalTrials.gov, and SEC EDGAR. We do not rely on third-party aggregators as primary sources.
FDA calendar data is updated daily. Insider trading data (SEC Form 4) is processed within hours of filing. Hedge fund holdings (13F) are updated quarterly. Blog content is reviewed and refreshed when underlying data changes.
Our POA scores are generated using a combination of historical FDA approval rates by therapeutic area, clinical trial endpoint data, regulatory designation status, and advisory committee outcomes. Each POA includes a detailed summary explaining the reasoning.
All published analysis is reviewed by team members with biotech domain expertise. We cite primary sources in every article. If we discover an error, we correct it within 24 hours and note the correction inline. AI-assisted research is always reviewed and edited by a human before publication.
Integrity, excellence, and innovation are the pillars of our approach. We are committed to providing independent and objective research, combining rigorous analysis with cutting-edge technology to ensure our users receive the most reliable and relevant information. We are not affiliated with any pharmaceutical company, broker-dealer, or investment fund.
Join BiopharmaWatch and experience a new level of insight and expertise in biotech and pharma investing. For more information or inquiries, please contact our support team. We are here to help you navigate the market with confidence.
Welcome to BiopharmaWatch. Your trusted guide to informed biotech and pharma investing.
Disclaimer: BiopharmaWatch provides data and analysis for informational and educational purposes only. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. Always consult a qualified financial advisor before making investment decisions. Data is sourced from FDA, SEC, and ClinicalTrials.gov and is believed to be accurate but is not guaranteed.